Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
March 02, 2023 11:14 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Ordinær generalforsamling i ALK-Abelló A/S den 23. marts 2023
February 27, 2023 04:00 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): Ordinær generalforsamling i ALK-Abelló A/S finder sted torsdag den 23. marts 2023 kl. 16.00 hos ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm i henhold til vedhæftede...
Annual General Meeting in ALK on 23 March 2023
February 27, 2023 04:00 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 23 March 2023 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm, Denmark. The...
ALK udnævner Claus Steensen Sølje som ny finansdirektør (CFO)
February 10, 2023 02:30 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) har i dag meddelt, at Claus Steensen Sølje tiltræder stillingen som Executive Vice President (koncerndirektør), finansdirektør (CFO) og medlem af direktionen senest...
ALK appoints Claus Steensen Sølje as new Chief Financial Officer (CFO)
February 10, 2023 02:30 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that Claus Steensen Sølje will take up the position as Executive Vice President, Chief Financial Officer (CFO) and member of the Board of Management...
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
February 08, 2023 11:04 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
February 08, 2023 11:04 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Registreringsansøgning for ALK's tablet mod husstøvmideallergi accepteret til behandling i Kina
February 03, 2023 06:48 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) meddelte i dag, at National Medical Products Administration (NMPA) i Kina har accepteret at behandle selskabets registreringsansøgning for tabletten mod...
Regulatory filing for house dust mite allergy tablet accepted for review in China
February 03, 2023 06:48 ET
|
ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that its Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy immunotherapy (AIT) tablet has been accepted...
Årsrapport 2022: ALK leverer salgsvækst på 13 % og indtjeningsvækst på 33 % i 2022
February 03, 2023 06:08 ET
|
ALK Abello
ALK's (ALKB:DC / OMX: ALK B / AKBLF) bestyrelse har i dag godkendt selskabets årsrapport for 2022 (ESEF-version ALK-2022-12-31-en vedhæftet). Årets resultat overgik de oprindelige forventninger og var...